The burden of disease in Greece, health loss, risk factors, and health financing, 2000–16: an analysis of the Global Burden of Disease Study 2016

Stefanos Tyrovolas(University of Washington), Nick J Kassebaum(University of Washington), Andy Stergachis(University of Washington), Haftom Niguse Abraha(University of Washington), François Alla(University of Washington), Sofia Androudi(University of Washington), Mate Car(University of Washington), Vanessa Chrepa(University of Washington), Nancy Fullman(University of Washington), Thomas Fürst(University of Washington), Josep María Haro(University of Washington), Simon I Hay(University of Washington), Mihajlo Jakovljević(University of Washington), Jost B. Jonas(University of Washington), Ibrahim A Khalil(University of Washington), Jacek A Kopec(University of Washington), Helena Manguerra(University of Washington), Ira Martopullo(University of Washington), Ali H. Mokdad(University of Washington), Lorenzo Monasta(University of Washington), Emma Nichols(University of Washington), Helen Elizabeth Olsen(University of Washington), Salman Rawaf(University of Washington), Robert C. Reiner(University of Washington), André M. N. Renzaho(University of Washington), Luca Ronfani(University of Washington), María Dolores Sánchez-Niño(University of Washington), Benn Sartorius(University of Washington), Dayane Gabriele Alves Silveira(University of Washington), Vasiliki Stathopoulou(University of Washington), Emil Stein Vollset(University of Washington), Konstantinos Stroumpoulis(University of Washington), Monika Sawhney(University of Washington), Roman Topór-Mądry(University of Washington), Fotis Topouzis(University of Washington), Miguel Tortajada‐Girbés(University of Washington), Miltiadis K. Tsilimbaris(University of Washington), Nikolaos Tsilimparis(University of Washington), Dimitrios Valsamidis(University of Washington), Job F. M. van Boven(University of Washington), Francesco Saverio Violante(University of Washington), Andrea Werdecker(University of Washington), Ronny Westerman(University of Washington), Harvey Whiteford(University of Washington), Charles Wolfe(University of Washington), Mustafa Z Younis(University of Washington), Georgios A. Kotsakis(University of Washington)
The Lancet Public Health
July 25, 2018
Cited by 67Open Access
Full Text

Abstract

BACKGROUND: Following the economic crisis in Greece in 2010, the country's ongoing austerity measures include a substantial contraction of health-care expenditure, with reports of subsequent negative health consequences. A comprehensive evaluation of mortality and morbidity is required to understand the current challenges of public health in Greece. METHODS: We used the results of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to describe the patterns of death and disability among those living in Greece from 2000 to 2010 (pre-austerity) and 2010 to 2016 (post-austerity), and compared trends in health outcomes and health expenditure to those in Cyprus and western Europe. We estimated all-cause mortality from vital registration data, and we calculated cause-specific deaths and years of life lost. Age-standardised mortality rates were compared using the annualised rate of change (ARC). Mortality risk factors were assessed using a comparative risk assessment framework for 84 risk factors and clusters to calculative summary exposure values and population attributable fraction statistics. We assessed the association between trends in total, government, out-of-pocket, and prepaid public health expenditure and all-cause mortality with a segmented correlation analysis. FINDINGS: All-age mortality in Greece increased from 944·5 (95% uncertainty interval [UI] 923·1-964·5) deaths per 100 000 in 2000 to 997·8 (975·4-1018) in 2010 and 1174·9 (1107·4-1243·2) in 2016, with a higher ARC after 2010 and the introduction of austerity (2·72% [1·65 to 3·74] for 2010-16) than before (0·55% [0·24 to 0·85] for 2000-10) or in western Europe during the same period (0·86% [0·54 to 1·17]). Age-standardised reduction in ARC approximately halved from 2000-10 (-1·61 [95% UI -1·91 to -1·30]) to 2010-16 (-0·87% [-2·03 to 0·20]), with post-2010 ARC similar to that in Cyprus (-0·86% [-1·4 to -0·36]) and lower than in western Europe (-1·14% [-1·48 to -0·81]). Mortality changes in Greece coincided with a rapid decrease in government health expenditure, but also with aggregate population ageing from 2010 to 2016 that was faster than observed in Cyprus. Causes of death that increased were largely those that are responsive to health care. Comparable temporal and age patterns were noted for non-fatal health outcomes, with a somewhat faster rise in years lived with disability since 2010 in Greece compared with Cyprus and western Europe. Risk factor exposures, especially high body-mass index, smoking, and alcohol use, explained much of the mortality increase in Greek adults aged 15-49 years, but only explained a minority of that in adults older than 70 years. INTERPRETATION: The findings of increases in total deaths and accelerated population ageing call for specific focus from health policy makers to ensure the health-care system is equipped to meet the needs of the people in Greece. FUNDING: Bill & Melinda Gates Foundation.


Related Papers

No related papers found

Powered by citation graph analysis